NCT02023164View on ClinicalTrials.gov

Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Acute Urticaria
Interventions
DRUG

JDP-205 Injection

Cetirizine, 10mg/mL; a single 1.0 mL injection via intravenous (IV) push over a period of \~2 minutes

DRUG

Diphenhydramine

Diphenhydramine Injection, 50 mg/mL; a single 1.0 mL injection via intravenous (IV) push over a period of \~2 minutes

Trial Locations (6)

43210

OSU Hospitals, Department of Emergency Medicine, Columbus

45267-0769

University of Cincinnati, Department of Emergency Medicine, Cincinnati

Unknown

Glengarry Memorial Hospital, Independent Practice, Alexandria

Ottawa Hospital, Civic Campus, Ottawa

M5B 1W8

St. Michael's Hospital, Toronto

H3G 1L5

Del Carpio Independent Practice, Montreal

Sponsors
All Listed Sponsors
lead

JDP Therapeutics, Inc.

INDUSTRY